NCT06279026
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- The Second Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Clinical trial condition
Relapsed/Refractory Multiple Myeloma
Explore clinical trials studying Relapsed/Refractory Multiple Myeloma. Study availability and eligibility vary by location and protocol.
49 public trials
21 recruiting studies
Relapsed/Refractory Multiple Myeloma trial results
Enrolling by Invitation
Long-Term Follow-up Study
NCT05332054
- Conditions
- B Cell Lymphoma, B-cell Non-Hodgkin's Lymphoma, Blood Protein Disorders, +29 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- Honor Health Research Institute Scottsdale, Arizona, United States
- University of California Irvine Irvine, California, United States
NCT07727668
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
NCT07510100
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
- Locations
-
- Institute of Science Tokyo Hospital Bunkyo-ku, Tokyo, Japan
- Nihon University Itabashi Hospital Itabashi-ku, Tokyo, Japan
- Japanese Red Cross Medical Center Shibuya-ku, Tokyo, Japan
Not Yet Recruiting
A Collaborative Community Effort Using Belantamab Mafodotin in Relapsed/Refractory Myeloma
NCT05874193
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Johnston Hematology and Oncology of Clayton Clayton, North Carolina, United States
- Maria Parham Hospital Henderson, North Carolina, United States
- Scotland Health Care System Laurinburg, North Carolina, United States
- UNC Health Southeastern Lumberton, North Carolina, United States
Not Yet Recruiting
LCAR-M61SQ in Treatment of Relapsed/Refractory Multiple Myeloma
NCT06888752
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
Not specified
Not Yet Recruiting
A Real-World Observational Study: Zevorcabtagene Autoleucel Injection in Patients with Relapsed/Refractory Multiple Myeloma
NCT06659770
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
Not specified
Not Yet Recruiting
An Exploratory Study of RD140 Injection in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
NCT06655519
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
Not specified
Not Yet Recruiting
LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma
NCT06472479
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Anhui Cancer Hospital Hefei, Anhui, China
- Henan Cancer Hospital Zhengzhou, Henan, China
- Jiangsu Province Hospital Nanjing, Jiangsu, China
- Beijing Gobroad Hospital Beijing, China
Not Yet Recruiting
A Real World Study of Equecabtagene Autoleucel in Subjects With Relapsed and Refractory Multiple Myeloma.
NCT06369935
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Peking University People's Hospital Beijing, China